JP2026063215A5 - - Google Patents

Info

Publication number
JP2026063215A5
JP2026063215A5 JP2026005807A JP2026005807A JP2026063215A5 JP 2026063215 A5 JP2026063215 A5 JP 2026063215A5 JP 2026005807 A JP2026005807 A JP 2026005807A JP 2026005807 A JP2026005807 A JP 2026005807A JP 2026063215 A5 JP2026063215 A5 JP 2026063215A5
Authority
JP
Japan
Prior art keywords
cells
composition
nucleic acid
arginine
genetically modified
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2026005807A
Other languages
English (en)
Japanese (ja)
Other versions
JP2026063215A (ja
Filing date
Publication date
Priority claimed from PCT/CN2021/077002 external-priority patent/WO2021164753A1/en
Application filed filed Critical
Publication of JP2026063215A publication Critical patent/JP2026063215A/ja
Publication of JP2026063215A5 publication Critical patent/JP2026063215A5/ja
Pending legal-status Critical Current

Links

JP2026005807A 2020-02-21 2026-01-16 免疫細胞においてアルギニン濃度をモジュレートするための方法および組成物 Pending JP2026063215A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US202062979805P 2020-02-21 2020-02-21
US62/979,805 2020-02-21
PCT/CN2021/077002 WO2021164753A1 (en) 2020-02-21 2021-02-20 Methods and compositions for modulating arginine levels in immune cells
JP2022550673A JP2023515806A (ja) 2020-02-21 2021-02-20 免疫細胞においてアルギニン濃度をモジュレートするための方法および組成物

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2022550673A Division JP2023515806A (ja) 2020-02-21 2021-02-20 免疫細胞においてアルギニン濃度をモジュレートするための方法および組成物

Publications (2)

Publication Number Publication Date
JP2026063215A JP2026063215A (ja) 2026-04-10
JP2026063215A5 true JP2026063215A5 (cg-RX-API-DMAC7.html) 2026-04-22

Family

ID=77390457

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022550673A Pending JP2023515806A (ja) 2020-02-21 2021-02-20 免疫細胞においてアルギニン濃度をモジュレートするための方法および組成物
JP2026005807A Pending JP2026063215A (ja) 2020-02-21 2026-01-16 免疫細胞においてアルギニン濃度をモジュレートするための方法および組成物

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2022550673A Pending JP2023515806A (ja) 2020-02-21 2021-02-20 免疫細胞においてアルギニン濃度をモジュレートするための方法および組成物

Country Status (13)

Country Link
US (1) US20230265386A1 (cg-RX-API-DMAC7.html)
EP (1) EP4107254A4 (cg-RX-API-DMAC7.html)
JP (2) JP2023515806A (cg-RX-API-DMAC7.html)
KR (1) KR20220157396A (cg-RX-API-DMAC7.html)
CN (1) CN115427553A (cg-RX-API-DMAC7.html)
AR (1) AR121392A1 (cg-RX-API-DMAC7.html)
AU (1) AU2021223138A1 (cg-RX-API-DMAC7.html)
BR (1) BR112022016571A2 (cg-RX-API-DMAC7.html)
CA (1) CA3171901A1 (cg-RX-API-DMAC7.html)
IL (1) IL295606A (cg-RX-API-DMAC7.html)
MX (1) MX2022010280A (cg-RX-API-DMAC7.html)
TW (1) TW202144569A (cg-RX-API-DMAC7.html)
WO (1) WO2021164753A1 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB202018554D0 (en) * 2020-11-25 2021-01-06 Cancer Research Tech Ltd Nucleic acid constructs and cells
CN114788870B (zh) * 2022-04-29 2023-06-06 浙江大学 靶向免疫细胞长效补充精氨酸并中和酸环境的组合物及应用
WO2026063691A1 (ko) * 2024-09-20 2026-03-26 삼성바이오에피스 주식회사 아르기니노숙시네이트 합성효소를 암호화하는 코돈-최적화된 폴리뉴클레오티드 및 이를 포함하는 rAAV 생산용 플라스미드

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013151664A1 (en) * 2012-04-02 2013-10-10 modeRNA Therapeutics Modified polynucleotides for the production of proteins
EP3525803B1 (en) * 2016-10-13 2022-12-07 Juno Therapeutics, Inc. Immunotherapy methods and compositions involving tryptophan metabolic pathway modulators
GB201701332D0 (en) * 2017-01-26 2017-03-15 Tc Biopharm Ltd Immune cells with modified metabolism and their use thereof
GB201721833D0 (en) * 2017-12-22 2018-02-07 Cancer Research Tech Ltd Fusion proteins

Similar Documents

Publication Publication Date Title
JP7546925B2 (ja) 核酸とcar修飾免疫細胞とを含む治療薬およびその使用
AU2017297610B2 (en) Compositions and methods for alphavirus vaccination
CA2909432C (en) ENHANCED CELLULAR IMMUNOTHERAPY
WO2019080537A1 (zh) 包含溶瘤病毒和car-nk细胞的治疗剂及应用、药盒、治疗肿瘤和/或癌症的方法
WO2012172277A4 (en) Simian adenovirus and hybrid adenoviral vectors
CN115820696A (zh) 治疗性多价HPV mRNA疫苗及其制备方法
CN101580817A (zh) 含有细胞因子诱导杀伤细胞的细胞群的制造方法
JP2026077634A (ja) がん処置のためのベクター
CN113481167B (zh) 一种免疫细胞外泌体及其应用
JP2023515806A5 (cg-RX-API-DMAC7.html)
CN113416260B (zh) 靶向Claudin18.2的特异性嵌合抗原受体细胞及其制备方法和应用
CA3171901A1 (en) Methods and compositions for modulating arginine levels in immune cells
CN111499766B (zh) 针对慢性淋巴细胞白血病的免疫效应细胞、其制备方法和应用
CN113832115A (zh) 融合基因ril-7联合ccl19重组溶瘤牛痘病毒及其在制备抗肿瘤药物中的应用
WO2025157249A1 (zh) 一种自复制rna及其用途
CN115975056B (zh) 利用天然蛋白tsh作为抗原结合位点构建靶向tshr的car-t细胞
CN102898508B (zh) 封闭TGF-β受体或IL-10受体的多肽、其药物组合物及其用途
CN105585637A (zh) 基于il-12稳定膜表达的肿瘤治疗剂及其制法和用途
TWI259206B (en) A DNA vaccine containing a tumor associated gene and a cytokine gene and the method producing thereof
CN1517437B (zh) 特异性治疗肿瘤或胞内感染的疫苗及应用
EP4326884A1 (en) Adenovirus for treatment of cancer
JP7572102B2 (ja) 腫瘍溶解性遺伝子改変麻疹ウイルスの新規用途
HK40049493A (en) Therapeutic agent comprising nucleic acid and car-modified immune cell and application thereof
Xia et al. Engineered bacteriophage nanoassemblies in vivo stabilize DC–T cell immune synapse for high-performance influenza vaccination
WO2025119999A1 (en) Extracellular vesicle based vaccine platform